Showing results (1-10 of 244) with videos related to
Sort By:
Pageof 25
Cancer Journal (Sudbury, Mass.)|September 22, 2021
From Bench to Bedside: The Evolution of Genomics and Its Implications for the Current and Future Management of Multiple MyelomaGareth J Morgan, Eileen M Boyle, Faith E DaviesExploration of Targeted Anti-Tumor Therapy|September 1, 2022
The evolving role and utility of off-label drug use in multiple myelomaJames H Stoeckle, Faith E Davies, Louis Williams, et al.Hematology. American Society of Hematology. Education Program|December 10, 2017
Is molecular remission the goal of multiple myeloma therapy?Faith E DaviesLeukemia|February 3, 2022
Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patientsJessica Caro, Marc Braunstein, Louis Williams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
Predicting the Future: Machine-Based Learning for MRD PrognosticationCharlotte Pawlyn, Faith E DaviesBlood|December 28, 2018
Toward personalized treatment in multiple myeloma based on molecular characteristicsCharlotte Pawlyn, Faith E DaviesCurrent Oncology Reports|August 17, 2011
Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphomaEileen M Boyle, Franck MorschhauserJournal of Experimental & Clinical Cancer Research : CR|December 3, 2021
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancerHussein Ghamlouch, Eileen M Boyle, Patrick Blaney, et al.Experimental Hematology & Oncology|February 26, 2025
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow nicheHussein Ghamlouch, Dylan C Gagler, Patrick Blaney, et al.Haematologica|May 15, 2012
DangER: protein ovERload. Targeting protein degradation to treat myelomaLauren I Aronson, Faith E DaviesPageof 25